Pollock, J., Polverino, E., Dhar, R., et al. Thorax, 2025

Aspergillus Serologic findings and clinical Outcomes in Patients With Bronchiectasis: Data From the European Bronchiectasis Registry

Pollock, J., Goeminne, P.C., Aliberti, S., et al. Chest, 2025

EMBARCing on a new era for bronchiectasis: a review series for the Seventh World Bronchiectasis Conference

Chalmers, J.D., Goeminne, P.C., Ringshausen, F.C. Eur Respir Rev, 2024

Eradication treatment for Pseudomonas aeruginosa infection in adults with bronchiectasis: a systematic review and meta-analysis.

Conceicao, M., Shteinberg M., Goeminne P.C. et al. Eur Respir Rev, 2024

Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)

Spinou, A., Hererro-Cortina, B., Aliberti, S., et al. Eur Respir J, 2024

Diagnostic delay and access to care in bronchiectasis: data from the EMBARC/ELF patient survey

Spinou, A., Almagro, M., Harris, B., et al. Eur Respir J, 2024

Endotypes of exacerbation in bronchiectasis: an observational cohort study

Gao, Y., Richardson, H., Dicker, A.J., et al. Am J Respir Crit Care Med, 2024

Sputum metagenomics of people with bronchiectasis

Rosenboom, I., Thavarasa, A., Richardson, H., et al. ERJ Open Res, 2024

Eradication treatment for Pseudomonas aeruginosa infection in adults with bronchiectasis: a systematic review and meta-analysis

Conceição, M., Shteinberg, M., Goeminne, P., et al. Eur Respir Rev, 2024

Prescribing preferences and availability of nebulisers and inhalers for inhaled medications in bronchiectasis: results of a specialist survey

Shteinberg, M., Spinou, A., Goeminne, P., et al. ERJ Open Res, 2024

Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC) 

Polverino, E., Dimakou, K., Traversi, L., et al.  J Allergy Clin Immunol, 2024 

The Association Between Bronchiectasis and Chronic Obstructive Pulmonary Disease: Data from the European Bronchiectasis Registry (EMBARC)   

Polverino, E., De Soyza, A., Dimakou, K., et al.  Am J Respir Crit Care Med, 2024 

Airway IL-1B is related to disease severity and mucociliary function in bronchiectasis

Perea, L., Bottier, M., Cant, E., et al. Eur Respir J, 2024

Structural Lung Disease and Clinical Phenotype in Bronchiectasis Patients: The EMBARC CT Study 

Pieters, A. L. P., van der Veer, T., Meerburg, J. J., et al.  Am J Respir Crit Care Med, 2024 

Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC) 

Aliberti, S., Ringshausen, F. C., Dhar, R., et al.  Eur Respir J, 2024 

Bronchiectasis management in adults: state of the art and future directions

Choi, H., McShane, P.J., Aliberti, S., et al. Eur Respir J, 2024

Rethinking bronchiectasis as an inflammatory disease

Long, M.B., Chotirmall, S.H., Shteinberg, M & Chalmers, J.D. Lancet Respir Med, 2024

The Efficacy and Safety of Inhaled Antibiotics for the Treatment of Bronchiectasis in Adults: Updated Systematic Review and Meta-Analysis

Cordeiro, R., Choi, H., Haworth, C.S., Chalmers, J.D. CHEST, 2024

Airway ‘Resistotypes’ and clinical Outcomes in Bronchiectasis

Mac Aogain, M., Ivan F.X., Jaggi, T.K et al. AJRCCM, 2024

A Bispecific Monoclonal Antibody Targeting Psl and PcrV Enhances Neutrophil-Mediated Killing of Pseudomonas aeruginosa in Patients with Bronchiectasis

Long, M.B., Gilmour, A., Kehl, M., et al. AJRCCM, 2024

The Precision Medicine Era of Bronchiectasis

Chotirmall, S.H. & Chalmers, J.D. AJRCCM, 2024

Clinical outcomes of bronchiectasis in India: data from the EMBARC/Respiratory Research Network of India registry

Dhar, R., Singh, S., Talwar, D., et al. Eur Respir J, 2023

Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)

Chalmers, J. D., Polverino, E., Crichton, M. L., et al. Lancet Respir Med, 2023

Transforming clinical research and science in bronchiectasis: EMBARC3, a European Respiratory Society Clinical Research Collaboration

Chalmers, J.D., Aliberti, S., Altenburg, J., et al. Eur Respir J, 2023

A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: Airleaf

Chalmers, J.D., Gupta, A., Chotirmall, S.H., et al. ERJ Open Res, 2023

Airway clearance treatments in bronchiectasis: feasibility of linking survey results to registry data and a survey of patients’ and physiotherapists’ practices

McLeese, R.H., O’Neill, K., O’Neill, B., et al. ERJ Open Res, 2023

Inflammatory molecular endotypes in bronchiectasis: a European multicenter cohort study

Choi, H., Ryu, S., Keir, H.R., et al. Am J Respir Crit Care Med, 2023

Intermittent prophylactic antibiotics for bronchiectasis

Spencer, S., Donovan, T., Chalmers, J.D., et al. Cochrane Database Syst Rev, 2022

Characterisation of Eosinophilic Bronchiectasis: A European Multicohort Study

Shoemark, A., Shteinberg, M., De Soyza, A., et al. AJRCCM, 2022.

Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations

Aliberti, S., Goeminne, P.C., O’Donnel, A.E., et al. Lancet Respir Med, 2022

Endotyping Chronic Obstructive Pulmonary Disease, Bronchiectasis, and the ‘Chronic Obstructive Pulmonary disease-Bronchiectasis Association’

Huang, J.T.J., Cant, E., Keir, H.R., et al. AJRCCM, 2022

Sputum Proteomics in Nontuberculous Mycobacterial Lung Disease

Hull, R.C., Huang, J.T.J., Barton, A.K., et al. CHEST, 2022

Heterogeneity of treatment response in bronchiectasis clinical trials

Sibila, O., Laserna, E., Shoemark, A., et al. Eur Respir J, 2022

Critical appraisal of international adult bronchiectasis guidelines using the AGREE II tool

Tejada, S., Ramirez-Estrada, S., Tejo, A.M., et al. Eur J Intern Med, 2022

ROSE: radiology, obstruction, symptoms and exposure – a Delphi consensus definition of the association of COPD and bronchiectasis by the EMBARC Airways Working Group

Traversi, L., Miravitlles, M., Martinez-Garcia, M. A., et al. ERJ Open Res, 2021

What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey

Shteinberg, M., Boyd, J., Aliberti, S., et al. ERJ Open Res, 2021

Patients’ perspectives on bronchiectasis: findings from a social media listening study

Delestre-Levai, I., Aliberti, S., Almagro, M., et al. ERJ Open Res, 2021

Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study

Keir, H.R., Shoemark, A., Dicker, A.J., et al. Lancet Respir Med, 2021

Validation of the Bronchiectasis Impact Measure (BIM): a novel patient-reported outcome measure

Crichton, M.L., Dudgeon, E.K., Shoemark, A., et al. Eur Respir J, 2021

BronchUK: protocol for an observational cohort study and biobank in bronchiectasis

De Soyza, A., Mawson, P., Hill, A.T., et al. ERJ Open Res, 2021

The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study

Dicker, A.J., Lonergan, M. Keir, H.R., et al. The Lancet, 2021

Characteristics of bronchiectasis in Korea: First data from the Korean Multicentre Bronchiectasis Audit and Research Collaboration registry and comparison with other international registries

Lee, H., Choi H., Chalmers, J.D. et al. Respirology, 2021

Relationship between Symptoms, Exacerbations, and Treatment Response in Bronchiectasis

Yong-Hua, G., Abo-Leyah, H., Finch, S., et al. Am J Respir Crit Care Med, 2020

Development and initial validation of the bronchiectasis exacerbation and symptom tool (BEST)

Artaraz, A., Crichton, M.L., Finch, S., et al. Respir Res, 2020

Inhaled aztreonam improves symptoms of cough and sputum production in patients with bronchiectasis: a post hoc analysis of the AIR-BX studies

Crichton, M.L., Lonergan, M., Baker, A.F., et al. Eur Respir J, 2020

Recommendations for travelling with bronchiectasis: a joint ELF/EMBARC/ERN-Lung collaboration

Shteinberg, M., Crossley, B., Lavie, T., et al. ERJ Open Res, 2019

Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry

Dhar, R., Singh, S., Talwar, D., et al. Lancet Glob Health, 2019

A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults

Crichton, M.L., Aliberti S., Chalmers, J.D., Eur Respir Rev, 2019

Antimicrobial peptides, disease severity and exacerbations in bronchiectasis

Sibila, O., Perea L., Cantó, E., et al. Thorax, 2019

Airway Bacterial Load and Inhaled Antibiotic Response in Bronchiectasis

Sibila, O., Laserna, E., Shoemark, A., et al. Am J Respir Crit Care Med, 2019

A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation

Shoemark, A., Cant, E., Carreto, L., et al. Eur Respir J, 2019

Personalised anti-inflammatory therapy for bronchiectasis and cystic fibrosis: selecting patients for controlled trials of neutrophil elastase inhibition

Keir, H. R., Fong, C. J., Crichton, M.L., et al. ERJ Open Res, 2019

Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis

Altenburg, J., Chalmers, J.D., Lonergan, M., et al. Eur Respir J, 2019

Bronchiectasis Guidelines: Recommendations into Practice

Redondo, M., and Chalmers, J.D. Arch Bronconeumol (Engl Ed), 2019

The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis

Laska, I.F., Crichton, M.L., Shoemark, A., et al. Lancet Respir Med, 2019

Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network

Chalmers, J. D., Ringshausen, F. C., Harris, B., et al. Eur Respir J, 2018

The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) ERS Clinical Research Collaboration

Aliberti, S., Polverino, E., Chalmers, J. D., et al. Eur Respir J, 2018

The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions

Polverino, E., Dimakou, K., Hurst, J., et al. Eur Respir J, 2018

Continuous versus intermittent antibiotics for bronchiectasis

Donovan, T., Felix, L.M., Chalmers, J.D., et al. Cochrane Database Syst Rev, 2018

Characterization of the “Frequent Exacerbator Phenotype” in Bronchiectasis

Chalmers, J.D., Alibert, S., Filonenko, A., et al. Am J Respir Crit Care Med, 2018

The impact of acute air pollution fluctuations on bronchiectasis pulmonary exacerbation: a case-crossover analysis

Geominne, P. C., Cox, B., Finch, S., et al. Eur Res J, 2018

Bronchiectasis Rheumatoid Overlap Syndrome Is an Independent Risk Factor for Mortality in Patients With Bronchiectasis: A Multicenter Cohort Study

De Soyza, A., McDonnell, M. J., Goeminne, P. C., et al. Chest, 2017

Patient participation in ERS guidelines and research projects: the EMBARC experience

Chalmers, J. D., Timothy, A., Polverino, E., et al. Breathe (Sheff), 2017

The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration

Chalmers, J. D., Crichton, M., Goeminne, P. C., et al. Breathe (Sheff), 2017

European Respiratory Society guidelines for the management of adult bronchiectasis

Polverino, E., Goeminne, P.C., McDonnell, M.J., et al. Eur Respir J, 2017

Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research

Hill, A.T., Haworth, C.S., Aliberti, S., et al. Eur Respir J, 2017

Neutrophil Elastase Activity is Associated with Exacerbations and Lung Functions Decline in Bronchiectasis

Chalmers, J.D, Moffitt, K. L., Suarez-Cuartin, G. et al. Am J Respir Crit Care Med,  2017

The EMBARC European Bronchiectasis Registry: protocol for an international observational study

Chalmers, J. D., Aliberti, S., Polverino, E., et al. ERJ Open Res, 2016

Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration

Aliberti, S., Masefield, S., Polverino, E., et al. Eur Respir J, 2016

Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study

McDonnell, M.J., Aliberti, S., Goeminne, P.C., et al. Lancet Respir Med, 2016

COPD and bronchiectasis: phenotype, endotype or co-morbidity?

Blasi, F., Chalmers, J.D., Aliberti, S. COPD, 2014